Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
21.55
+0.73 (3.51%)
At close: Oct 9, 2026, 4:00 PM EDT
21.53
-0.02 (-0.09%)
After-hours: Oct 9, 2026, 5:42 PM EDT

Omada Health Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Omada Health stock has a consensus rating of "Buy" and an average price target of $28.42. The average 1-year stock price forecast is 31.88% higher than the current stock price, while the lowest is $22 (+2.09%) and the highest is $35 (+62.41%).

Price Target: $28.42 (+31.88%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$22$28.42$28$35
Change+2.09%+31.88%+29.93%+62.41%

Analyst Ratings

The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jul '26Aug '26Sep '26Oct '26
Strong Buy555555
Buy555555
Hold222222
Sell000000
Strong Sell000000
Total121212121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Maintains
$30
BuyMaintains$30+39.21%Sep 28, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$22
HoldMaintains$22+2.09%Sep 15, 2026
Freedom Capital Markets
Freedom Capital Markets
Buy
Reiterates
$35
BuyReiterates$35+62.41%Sep 14, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$25
BuyMaintains$25+16.01%Sep 11, 2026
BMO Capital
BMO Capital
Buy
Reiterates
$24
BuyReiterates$24+11.37%Sep 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
338.70M
from 260.21M
Increased by 30.17%
Revenue Next Year
407.80M
from 338.70M
Increased by 20.40%
EPS This Year
0.44
from 0.15
Increased by 181.49%
EPS Next Year
0.56
from 0.44
Increased by 27.56%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
89.19M122.78M169.80M260.21M338.70M
Revenue Growth
-37.67%38.29%53.25%30.17%
Gross Profit
42.79M69.97M102.88M170.94M240.07M
Gross Margin
47.98%56.99%60.59%65.69%70.88%
Operating Income
-72.35M-66.00M-43.65M-11.97M2.98M
Net Income
-72.52M-67.51M-47.14M-12.78M7.23M
EPS
---0.150.44
EPS Growth
----181.49%
Forward PE
----49.43
Free Cash Flow
---16.93M33.77M
No. Analysts
----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High344.4M
Avg338.7M
Low336.9M

Revenue Growth

Revenue Growth202620272028
High
32.4%
Avg
30.2%
Low
29.5%

EPS Forecast

EPS202620272028
High0.48
Avg0.44
Low0.38

EPS Growth

EPS Growth202620272028
High
210.5%
Avg
181.5%
Low
145.3%